Artiva Biotherapeutics Reports Q3 2024 Financial Results

TipRanksNov 14 12:44

Needham Maintains Artiva Biotherapeutics(ARTV.US) With Buy Rating, Maintains Target Price $23

Futu NewsNov 13 19:36 · Ratings

Artiva Biotherapeutics, Inc.: Strong Buy Rating Supported by Robust Autoimmune Pipeline and Financial Stability

TipRanksNov 13 18:57 · Ratings

TD Cowen Maintains Artiva Biotherapeutics(ARTV.US) With Buy Rating

Futu NewsNov 13 10:31 · Ratings

Artiva Biotherapeutics, Inc. (ARTV) Receives a Buy From TD Cowen

TipRanksNov 13 10:05 · Ratings

Artiva Biotherapeutics Q3 EPS $(0.92) Misses $(0.91) Estimate

BenzingaNov 13 05:51